Article
Factors affecting surgical decision-making in carriers of BRCA1/2 pathogenic variants undergoing risk-reducing surgery at a dedicated hereditary ovarian cancer clinic.
Menopause (New York, N.Y.) - 6 Dec 2021
Jacobson Michelle R, Walker Melissa, Ene Gabrielle E V, Firestone Courtney, Bernardini Marcus Q, Allen Lisa, Huszti Ella, Sobel Mara
Abstract excerpt
OBJECTIVE: Women with germline BRCA1/2 pathogenic variants have a significantly elevated lifetime risk of ovarian and fallopian tube cancer. Bilateral salpingo-oophorectomy (RRSO) is associated with a 90% reduction in the development of tubal and ovarian cancer. At our tertiary hospital, we have a dedicated clinic where women predisposed to hereditary ovarian/tubal cancer receive counseling on reproduction, risk...
Topics
- BRCA1 Protein
- BRCA2 Protein
- Canada
- Clinical Decision-Making
- Female
- Genetic Predisposition to Disease
- Heterozygote
- Humans
- Middle Aged
- Mutation
